High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
K H AntmanMary M Horowitz

Abstract

To identify trends in high-dose therapy with autologous hematopoietic stem-cell support (autotransplants) for breast cancer (1989 to 1995). Analysis of patients who received autotransplants and were reported to the Autologous Blood and Marrow Transplant Registry. Between January 1, 1989 and June 30, 1995, 19,291 autotransplants were reviewed; 5,886 were for breast cancer. Main outcomes were progression-free survival (PFS) and survival. Between 1989 and 1995, autotransplants for breast cancer increased sixfold. After 1992, breast cancer was the most common indication for autotransplant. Significant trends included increasing use for locally advanced rather than metastatic disease (P < .00001) and use of blood-derived rather than marrow-derived stem cells (P < .00001). One-hundred-day mortality decreased from 22% to 5% (P < .0001). Three-year PFS probabilities were 65% (95% confidence intervals [Cls], 59 to 71) for stage 2 disease, and 60% (95% Cl, 53 to 67) for stage 3 disease. In metastatic breast cancer, 3-year probabilities of PFS were 7% (95% Cl, 4 to 10) for women with no response to conventional dose chemotherapy; 13% (95% Cl, 9 to 17) for those with partial response; and 32% (95% Cl, 27 to 37) for those with complete resp...Continue Reading

Citations

Oct 1, 1998·The New England Journal of Medicine·G N Hortobagyi
Nov 25, 1998·Journal of Clinical Apheresis·J A GagnonS Glück
Jun 16, 1999·Breast Cancer Research and Treatment·C Schmoor, M Schumacher
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H SchirrmeisterS N Reske
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D A RizzieriW P Peters
Feb 25, 2000·Cancer Practice·F Gaston-JohanssonM J Kennedy
Apr 13, 2000·Cancer Control : Journal of the Moffitt Cancer Center·B DjulbegovicD Sullivan
Jun 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A PatnaikM Crump
Oct 6, 2000·Bone Marrow Transplantation·H M PrinceD Rischin
Nov 25, 2000·Breast Cancer : the Journal of the Japanese Breast Cancer Society·T TajimaM Kubota
Dec 21, 2000·Current Oncology Reports·J G Schrama, S Rodenhuis
Nov 5, 2002·Annual Review of Medicine·Frederick R Appelbaum
Jun 1, 2004·American Journal of Clinical Oncology·Salomon M StemmerShulamith Rizel
Dec 29, 2005·International Journal of Cancer. Journal International Du Cancer·Vilde DragesetGunnar Kvalheim
Apr 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Aman U Buzdar
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael CrumpKathleen I Pritchard
Apr 15, 2016·Expert Review of Anticancer Therapy·Michael W DrazerSteven J Chmura
Feb 14, 1998·Journal of the National Cancer Institute·J ZujewskiJ Abrams
Feb 3, 2000·Journal of the National Cancer Institute·G N HortobagyiR E Champlin
Jun 2, 2000·Cancer Investigation·R D BaynesW P Peters
May 5, 2001·Breast Cancer Research and Treatment·E S WaiI A Olivotto
Sep 1, 2000·Bone Marrow Transplantation·L E DamonC A Linker
Jul 3, 2003·Bone Marrow Transplantation·J D RizzoK H Antman
Aug 10, 1999·American Journal of Clinical Oncology·D R FlemingR H Herzig

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J M VoseAutologous Blood and Marrow Transplant Registry Lymphoma Working Committee
© 2021 Meta ULC. All rights reserved